SOLAEROMED
SolAeroMed is a developer of a novel therapeutic used to treat obstructive lung diseases such as cystic fibrosis, bronchiectasis, asthma rescue drug, and other chronic obstructive lung diseases.
SOLAEROMED
Industry:
Biotechnology Pharmaceutical Therapeutics
Founded:
2011-01-01
Address:
Calgary, Alberta, Canada
Country:
Canada
Website Url:
http://www.solaeromed.com
Total Employee:
1+
Status:
Active
Contact:
403-969-7999
Total Funding:
101.04 K USD
Technology used in webpage:
Viewport Meta IPhone / Mobile Compatible SPF SSL By Default Google Font API LetsEncrypt WordPress Wordpress Plugins Mobile Non Scaleable Content Nginx
Current Employees Featured
John Dennis President & CEO @ SolAeroMed
President & CEO
Francis Green CSO & Co-Founder @ SolAeroMed
CSO & Co-Founder
Richard Leigh Clinical Lead @ SolAeroMed
Clinical Lead
Cora Pieron Drug Delivery @ SolAeroMed
Drug Delivery
Founder
Investors List
Official Site Inspections
http://www.solaeromed.com Semrush global rank: 6.11 M Semrush visits lastest month: 1.33 K
Unable to get host informations!!!
More informations about "SolAeroMed"
SolAeroMed - Crunchbase Company Profile & Funding
Organization. SolAeroMed . Connect to CRM . Save . Summary. Financials. People. Technology. Signals & News. Similar Companies. About. SolAeroMed …See details»
John Dennis - CEO - SolAeroMed Inc - LinkedIn
CEO at SolAeroMed Inc · 20 years past experience as university professor teaching and research areas of human health risk assessment, occupational and environmental pollution, and …See details»
SolAeroMed Company Profile | Management and Employees List
SolAeroMed Profile and History SolAeroMed Inc. is a Calgary, Canada based biotechnology company dedicated to the development of novel therapeutic strategies to treat obstructive lung …See details»
SolAeroMed Company Profile 2024: Valuation, Funding
SolAeroMed General Information Description. Developer of a novel therapeutic designed to treat obstructive lung diseases. The company offers novel therapies for diseases such as cystic …See details»
SolAeroMed - Overview, News & Similar companies | ZoomInfo.com
Who is SolAeroMed. SolAeroMed Inc. is a Calgary, Canada based biotechnology company dedicated to the development of novel therapeutic strategies to treat obstructive lung …See details»
SolAeroMed - Company Profile - Tracxn
Dec 5, 2024 SolAeroMed is involved in the development of therapeutic strategies to treat obstructive lung diseases. Its product offerings include: S-1226, in Phase II clinical trials as on …See details»
SolAeroMed - Products, Competitors, Financials, Employees, …
SolAeroMed is a company focused on the development of biophysical respiratory drugs and delivery devices within the healthcare sector. Their main offerings include therapeutic …See details»
SolAeroMed, Inc. - Drug pipelines, Patents, Clinical trials - Synapse
4 days ago Explore SolAeroMed, Inc. with its drug pipeline, therapeutic area, technology platform, 5 clinical trials, 2 news, and 4 literature, Disease Domain:Infectious Diseases, …See details»
SolAeroMed - Funding, Financials, Valuation & Investors
How much funding has this organization raised over time? Show . Announced Date . Transaction Name . Number of Investors . Money Raised . Lead Investors . Access exclusive financial …See details»
SolAeroMed - Crunchbase
SolAeroMed is a developer of a novel therapeutic used to treat obstructive lung diseases.See details»
SolAeroMed - VentureRadar
Similar Companies: Ockham Biotech United Kingdom Privately Held Ockham Biotech Ltd. is a research company which is focussed on the development of inhaled heparin for the treatment …See details»
Organization | SolAeroMed Inc. - Purdue University
Organization Overview. First Clinical Trial. 2014 NCT02616770. First Marketed Drug. None First NDA Approval. None Last Known Activity ... SolAeroMed Inc. Active Ingredients. Drugs in …See details»
Solaeromed - CoBee Company Profile & Funding Rounds
SolAeroMed is a developer of a novel therapeutic used to treat obstructive lung diseases such as cystic fibrosis, bronchiectasis, asthma rescue drug, and other chronic obstructive lung …See details»
SolAeroMed | Cambridge, MA, USA Startup - gust.com
Website solaeromed.com; Company Summary We provide drug products & services for the respiratory healthcare market. S-1226™, our lead candidate, is a rescue treatment for acute, …See details»
SolAeroMed - Contacts, Employees, Board Members, Advisors
Organization. SolAeroMed . Connect to CRM . Save . Summary. Financials. People. Technology. Signals & News. Similar Companies. Highlights. Employee Profiles 4. About. SolAeroMed has …See details»
SolAeroMed – lifesciencesalberta.com
SolAeroMed is a company dedicated to the development of novel therapeutic strategies to treat obstructive lung diseases. SKU: 199 Category ... Through its efforts, the organization …See details»
SolAeroMed - Raised $101K Funding from 3 investors - Tracxn
Dec 14, 2024 SolAeroMed has raised a total funding of $101K over 2 rounds from 3 investors. Investors include Innovate Calgary, Valhalla Angels and 1 other. Their latest funding round …See details»
SolAeroMed Inc. - CMOCRO
SolAeroMed aims to improve the quality and longevity of patients’ lives. This goal is being realized through the generation of quality biopharmaceutical technologies that are developed with …See details»
SolAeroMed - Tech Stack, Apps, Patents & Trademarks - Crunchbase
SolAeroMed is a developer of a novel therapeutic used to treat obstructive lung diseases.See details»
SolAeroMed | EquityNet
SolAeroMed is a company dedicated to the development of novel therapeutic strategies to treat obstructive lung diseases. We aim to improve the quality and longevity of patients lives. This …See details»